# If you had invested $1,000 in Novartis AG ADR (NVS)

Source: https://www.equity-rank.com/if-you-invested/NVS

10 years ago (Mon, Nov 7, 2016), $1,000 in NVS grew to **$4,246** by Fri, Nov 6, 2026 with dividends reinvested ($2,559 on price alone). The same $1,000 in SPY grew to $4,042. Along the way NVS fell as much as -26.0% from a high. Past results do not tell you what happens next.

| Invested | NVS, dividends reinvested | Per year | Worst fall | SPY | SPY per year |
| --- | --- | --- | --- | --- | --- |
| 1 year ago | $1,324 | +32.4% | -16.2% | $1,109 | +10.9% |
| 3 years ago | $1,928 | +24.5% | -20.0% | $1,750 | +20.5% |
| 5 years ago | $2,354 | +18.7% | -20.4% | $1,677 | +10.9% |
| 10 years ago | $4,246 | +15.6% | -26.0% | $4,042 | +15.0% |

Today: model fair value $176.61 against a $162.55 price (gap +8.7%).

Split-adjusted closes; 11 cash dividends reinvested on their ex-dividend dates, before taxes and costs. SPY on its total-return price. Data as of Fri, Nov 6, 2026.

[Full NVS valuation](https://www.equity-rank.com/stocks/NVS) · [Other companies](https://www.equity-rank.com/if-you-invested)

---

Fair value is a model estimate under stated assumptions — not a price target, not a prediction, and not a recommendation. This page is research information, not investment advice. Equity Rank is not a registered investment adviser.